Navigation Links
U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall
Date:8/16/2011

TUESDAY, Aug. 16 (HealthDay News) -- Many women in the United States continue to use a Chinese weight-loss supplement that's been recalled due to dangerous ingredients, a new study indicates.

Pai You Guo contains the pharmaceuticals sibutramine and phenolphthalein, both of which are banned in the United States because they increase the risk of heart attack, stroke and cancer.

The U.S. Food and Drug Administration announced a recall of Pai You Guo in 2009 but it appears to have had little effect on the number of women using the weight-loss product, this study suggests.

Harvard Medical School researchers surveyed more than 550 women who were born in Brazil and live in greater Boston and found that nearly one-quarter of them have used or currently use Pai You Guo. Most of the women using the supplement have experienced side effects such as insomnia, palpitations, fainting and addiction to the product.

The researchers also found that women who used the tainted supplement were three times more likely to purchase it in local stores than over the Internet.

The study was released online in advance of publication in an upcoming print issue of the Journal of General Internal Medicine.

"A strikingly high number of women are using weight-loss supplements marketed as all-natural products that are actually a dangerous mix of banned pharmaceuticals. This could have real public health consequences," study author Dr. Pieter Cohen, a general internist at Cambridge Health Alliance and an assistant professor of medicine at Harvard Medical School, said in a health alliance news release.

"Even when the supplements are known to be hazardous, the FDA lacks the ability to remove them from store shelves," he noted.

Until there are stronger regulations in the United States, people should not use any supplement that claims to help them lose weight, the researchers said.

More information

The U.S. Food and Drug Administration has more about fraudulent weight-loss supplements.

-- Robert Preidt

SOURCE: Cambridge Health Alliance, news release, Aug. 16, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Company Invites Women to STOP PMS - Take the 10-Minute Challenge
2. LifestyleMom.com and the LifestyleMom Radio Cafe Aim to Help Women Create a Family Life and "Me Life" That They Truly Love
3. Women More Likely to Fail Treatment for Atrial Fibrillation
4. Diabetes drug ups risk for bone fractures in older women
5. Womens Heart Disease Awareness Still Lacking
6. Cyndi Lauper, Lady Gaga Put Spotlight on Women and HIV
7. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
8. Womens Dermatologic Society Marks 35th Anniversary with Release of Unprecedented Book of Wisdom and Inspiration
9. Few Women at High Risk for Breast Cancer Take Tamoxifen
10. Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders
11. YazTalk Warns Women of Life Threatening Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall
(Date:5/23/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... company a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor ... proactively address potential cybersecurity threats before they happen. The annual list of ...
(Date:5/23/2017)... ... , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations and ... Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s Regulations ... today reported on a new study released on May 21, 2017 in the New ...
(Date:5/23/2017)... ... 23, 2017 , ... The Gallery of Cosmetic Surgery, founded ... to announce a new treatment option called Vivace Microneedling. This treatment option is ... body through a virtually pain-free, non-surgical treatment. Vivace Microneedling combines a state-of-the-art, best-in-class ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... video chat as a standard feature on its secure clinical communication platform. The ... voice to video depending on the type and urgency of a situation. ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... treatment using the SPEED System™ Orthodontics, with or without a referral, from the ... in El Segundo, CA, who is skilled in providing patients with the custom, ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
Breaking Medicine Technology: